FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890574909> ?p ?o ?g. }

• W2890574909 abstract "Glioblastoma multiforme (GBM) is a highly aggressive brain tumor in which cancer cells with stem cell-like features, called cancer stem cells (CSCs), were identified. Two CSC populations have been previously identified in GBM, one derived from the GBM area called enhanced lesion (GCSCs) and the other one from the brain area adjacent to the tumor margin (PCSCs) that greatly differ in their growth properties and tumor-initiating ability. To date the most effective chemotherapy to treat GBM is represented by alkylating agents such as temozolomide (TMZ), whose activity can be regulated by histone deacetylases (HDACs) inhibitors through the modulation of O6-methylguanine-DNA methyltransferase (MGMT) expression. Levetiracetam (LEV), a relatively new antiepileptic drug, modulates HDAC levels ultimately silencing MGMT, thus increasing TMZ effectiveness. However, an improvement in the therapeutic efficacy of TMZ is needed. Cell proliferation was investigated by BrdU cell proliferation assay and by Western Blot analysis of PCNA expression. Apoptosis was evaluated by Western Blot and Immunofluorescence analysis of the cleaved Caspase-3 expression. MGMT and HDAC4 expression was analyzed by Western Blotting and Immunofluorescence. Statistical analysis was performed using the Student’s t test and Mann–Whitney test. Here we evaluated the effect of TMZ on the proliferation rate of the IDH-wildtype GCSCs and PCSCs derived from six patients, in comparison with the effects of other drugs such as etoposide, irinotecan and carboplatin. Our results demonstrated that TMZ was less effective compared to the other agents; hence, we verified the possibility to increase the effect of TMZ by combining it with LEV. Here we show that LEV enhances the effect of TMZ on GCSCs proliferation (being less effective on PCSCs) by decreasing MGMT expression, promoting HDAC4 nuclear translocation and activating apoptotic pathway. Although further studies are needed to determine the exact mechanism by which LEV makes GBM stem cells more sensitive to TMZ, these results suggest that the clinical therapeutic efficacy of TMZ in GBM might be enhanced by the combined treatment with LEV." @default.
• W2890574909 created "2018-09-27" @default.
• W2890574909 creator A5016455095 @default.
• W2890574909 creator A5023386207 @default.
• W2890574909 creator A5025389870 @default.
• W2890574909 creator A5028910402 @default.
• W2890574909 creator A5045745542 @default.
• W2890574909 creator A5048564319 @default.
• W2890574909 creator A5075536730 @default.
• W2890574909 creator A5078135020 @default.
• W2890574909 creator A5089173622 @default.
• W2890574909 date "2018-09-10" @default.
• W2890574909 modified "2023-10-16" @default.
• W2890574909 title "Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis" @default.
• W2890574909 cites W1817360198 @default.
• W2890574909 cites W1893402990 @default.
• W2890574909 cites W1903052549 @default.
• W2890574909 cites W1972700706 @default.
• W2890574909 cites W1982198436 @default.
• W2890574909 cites W1987450508 @default.
• W2890574909 cites W1988378309 @default.
• W2890574909 cites W1989688017 @default.
• W2890574909 cites W1992913416 @default.
• W2890574909 cites W2001544973 @default.
• W2890574909 cites W2017883800 @default.
• W2890574909 cites W2018630332 @default.
• W2890574909 cites W2029148944 @default.
• W2890574909 cites W2040574920 @default.
• W2890574909 cites W2073280024 @default.
• W2890574909 cites W2074803464 @default.
• W2890574909 cites W2078510083 @default.
• W2890574909 cites W2096287682 @default.
• W2890574909 cites W2102085111 @default.
• W2890574909 cites W2104032759 @default.
• W2890574909 cites W2105252420 @default.
• W2890574909 cites W2106816824 @default.
• W2890574909 cites W2107263933 @default.
• W2890574909 cites W2107866319 @default.
• W2890574909 cites W2109531556 @default.
• W2890574909 cites W2110275053 @default.
• W2890574909 cites W2111042597 @default.
• W2890574909 cites W2120963683 @default.
• W2890574909 cites W2121113421 @default.
• W2890574909 cites W2123836229 @default.
• W2890574909 cites W2125464483 @default.
• W2890574909 cites W2125492018 @default.
• W2890574909 cites W2130511906 @default.
• W2890574909 cites W2134460746 @default.
• W2890574909 cites W2137548924 @default.
• W2890574909 cites W2138964047 @default.
• W2890574909 cites W2147129352 @default.
• W2890574909 cites W2158370459 @default.
• W2890574909 cites W2158751879 @default.
• W2890574909 cites W2167650288 @default.
• W2890574909 cites W2256998105 @default.
• W2890574909 cites W2366536035 @default.
• W2890574909 cites W2562451118 @default.
• W2890574909 cites W2602832336 @default.
• W2890574909 cites W2758830389 @default.
• W2890574909 cites W2790099097 @default.
• W2890574909 cites W2805756200 @default.
• W2890574909 cites W3189826866 @default.
• W2890574909 cites W4211107382 @default.
• W2890574909 doi "https://doi.org/10.1186/s12935-018-0626-8" @default.
• W2890574909 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6131782" @default.
• W2890574909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30214378" @default.
• W2890574909 hasPublicationYear "2018" @default.
• W2890574909 type Work @default.
• W2890574909 sameAs 2890574909 @default.
• W2890574909 citedByCount "33" @default.
• W2890574909 countsByYear W28905749092018 @default.
• W2890574909 countsByYear W28905749092019 @default.
• W2890574909 countsByYear W28905749092020 @default.
• W2890574909 countsByYear W28905749092021 @default.
• W2890574909 countsByYear W28905749092022 @default.
• W2890574909 countsByYear W28905749092023 @default.
• W2890574909 crossrefType "journal-article" @default.
• W2890574909 hasAuthorship W2890574909A5016455095 @default.
• W2890574909 hasAuthorship W2890574909A5023386207 @default.
• W2890574909 hasAuthorship W2890574909A5025389870 @default.
• W2890574909 hasAuthorship W2890574909A5028910402 @default.
• W2890574909 hasAuthorship W2890574909A5045745542 @default.
• W2890574909 hasAuthorship W2890574909A5048564319 @default.
• W2890574909 hasAuthorship W2890574909A5075536730 @default.
• W2890574909 hasAuthorship W2890574909A5078135020 @default.
• W2890574909 hasAuthorship W2890574909A5089173622 @default.
• W2890574909 hasBestOaLocation W28905749091 @default.
• W2890574909 hasConcept C121608353 @default.
• W2890574909 hasConcept C126322002 @default.
• W2890574909 hasConcept C2777389519 @default.
• W2890574909 hasConcept C2778227246 @default.
• W2890574909 hasConcept C28328180 @default.
• W2890574909 hasConcept C502942594 @default.
• W2890574909 hasConcept C54355233 @default.
• W2890574909 hasConcept C55427017 @default.
• W2890574909 hasConcept C62112901 @default.
• W2890574909 hasConcept C71924100 @default.
• W2890574909 hasConcept C86803240 @default.
• W2890574909 hasConceptScore W2890574909C121608353 @default.
• W2890574909 hasConceptScore W2890574909C126322002 @default.

• next